Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Henry Ford Health System | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A randomized clinical trial for patients with end stage renal disease in which a family consultation condition is compared against a treatment as usual control condition on the hospital readmissions after 1 month as the primary outcome variable.
Patients hospitalized at Henry For Hospital who have end stage renal disease will complete baseline questionnaires and be randomized into the experimental or control condition. Patients randomized into the experimental condition will have a single family consultation session before the patient is discharged. A trained, master's level therapist will conduct the family consultation, which will use education, motivational interviewing, and other techniques to help the family engage and support the patient's health needs. Patients in both the experimental and control conditions will complete follow up questionnaires 1 month after discharge. Investigators will conduct chart reviews of outcome data, including readmissions, at 1, 3, and 6 months post-discharge.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Family Consultation Condition | Experimental | The family consultation will be one, 1-hour session conducted by trained, master's level therapists. The goals of the meetings are: a) Review patient and family understanding of events that caused the hospital admission; b) increase family awareness of the level of cognitive impairment that the patient is experiencing; c) discuss ways the family can get involved and help the patient with their medication and dialysis adherence; d) use motivational interviewing techniques as needed. This will be provided in addition to the usual care that inpatients receive in this unit. |
|
| Treatment as Usual Control Condition | No Intervention | Standard of care for the nephrology unit. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Family Consultation | Behavioral | This intervention is based on psychoeducation, social support mobilization, and motivational interviewing techniques. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Early Hospital Readmissions - 1 Month | Were patients readmitted to the hospital within 1 month of their initial discharge? | 1 Month |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Instrumental Social Support | Amount of involvement of support people in terms of disease management. Items modified from the Diabetes Social Support Questionnaire-Family. | Baseline and 1-month follow-up |
| Change in Medication Adherence |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mark W Ketterer, Ph.D. | Henry Ford Health Systems | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Henry Ford Health System | Detroit | Michigan | 48202 | United States |
Not provided
| ID | Term |
|---|---|
| D007676 | Kidney Failure, Chronic |
| ID | Term |
|---|---|
| D051436 | Renal Insufficiency, Chronic |
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Adherence to medication regimen. Items modified from Immunosuppressant Therapy Adherence Scale.
| Baseline and 1-month follow-up |
| Change in Depression | Assessed using Patient Health Questionnaire 8 | Baseline and 1-month follow-up |
| Change in Anxiety | Assessed using Generalized Anxiety Disorder Questionnaire-7 | Baseline and 1-month follow-up |
| Change in Biological Measures of Health | Based on chart review, investigators will assess BUN, creatinine, substance use (tox screen), phosphorous, comorbidities, mortality | Baseline, 1, and 3 months |
| Hospital Readmissions - 3 Months | Were patients readmitted to the hospital within 3 months of their initial discharge? | 3 Months |
| D052776 |
| Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |